Effect of CPAP therapy on neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with obstructive sleep apnea.

S. Sökücü (Istanbul, Turkey)

Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Session: Efficacy of and compliance with obstructive sleep apnoea treatment
Session type: Thematic Poster
Number: 2275
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Sökücü (Istanbul, Turkey). Effect of CPAP therapy on neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with obstructive sleep apnea.. 2275

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of nCPAP therapy on inflammatory cell counts in pharyngeal lavage of patients with obstructive sleep apnea
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009


Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations
Source: International Congress 2017 – COPD and weaning
Year: 2017


Treatment of obstructive sleep apnea and the cytotoxic potential in peripheral blood lymphocytes
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Mean platelet volume in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010

Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Activated CD8 T-lymphocytes in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 820-828
Year: 2005



Mean platelet volume in obstructive sleep apnea patients. Another link to cardiovascular disease?
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Endothelial and systemic inflammation in obstructive sleep apnea syndrome: Impact of CPAP therapy on CRP plasma levels
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010


Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017


Effects of reduced lung volumes and age on oxyhemoglobin nocturnal desaturation in obstructive sleep apnea patients before and after CPAP treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011

Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease (overlap syndrome)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Circulating dendritic cell subsets are reduced in obstructive sleep apnoea patients: study correlation with inflammation markers
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019

Monocytes inhibit NK activity via TGF-ß in patients with obstructive sleep apnoea
Source: Eur Respir J, 49 (6) 1602456; 10.1183/13993003.02456-2016
Year: 2017



The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012

Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovasculer diseases
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011

Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003


The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 216s
Year: 2006

Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010